First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study-Reference-Cited by-同舟云学术

First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

Published:2022-04-06 Issue:8 Volume:148 Page:1869-1877
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kudo Kenichiro,Nishii Kazuya,Makimoto Go,Ishikawa Nobuhisa,Tsubata Yukari,Kodani Masahiro,Fujimoto Nobukazu,Yamasaki Masahiro,Kubota Tetsuya,Takigawa Nagio,Fujitaka Kazunori,Kanaji Nobuhiro,Shibayama Takuo,Itano Junko,Ando Chihiro,Hotta Katsuyuki^ORCID,Kiura Katsuyuki

Funder

the 2016 Chugoku Occupational Health Association Grant.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-021-03893-z.pdf

Reference29 articles.

1. Camidge DR, Pao W, Sequist LV (2014) Acquired resistance to TKIs in solid tumours: learning from lung cancer. Nat Rev Clin Oncol 11:473–481. https://doi.org/10.1038/nrclinonc.2014.104

2. Chabon JJ, Simmons AD et al (2016) Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nat Commun 7:11815. https://doi.org/10.1038/ncomms11815

3. Costanzo R, Montanino A, Di Maio M et al (2013) Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives. Expert Rev Anticancer Ther 13:1207–1218. https://doi.org/10.1586/14737140.2013.845092